Search

​According to this report, the use of rapid molecular assays has diagnostic value in tuberculosis (TB) identification and detection of drug resistance, although there is not enough evidence to recommend these tools in all populations and situations and they should not replace standard diagnostic methods.

Overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons.

This document provides support to healthcare workers when managing suspected or confirmed cases of novel coronavirus 2019 (COVID-19). Available in 26 languages.

This document provides guidance to EU/EEA Member States on environmental cleaning in healthcare and non-healthcare settings during the COVID-19 pandemic. Available in 26 languages.

This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities. It also offers guidance on the management of specimens at laboratories in the EU/EEA.

This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home.

This report provides updated 30-day projections, together with the inherent model assumptions and uncertainties. Both the model projections and the data to which the model is calibrated should be interpreted with caution given the differences between national surveillance systems, case definitions and testing policies. Comparisons between countries based on the data and forecasts presented in this paper should only be made with extreme caution and should take these differences into account. Nonetheless, the projections presented here illustrate potential future trends in COVID-19 transmission in EU/EEA countries and the UK.

It is of paramount importance to be able to rapidly identify, assess and control COVID-19 outbreaks in LTCFs in order to protect this particularly fragile population. This document provides guidance for EU/EEA Member States planning to implement monitoring systems at LTCFs and describes the surveillance objectives.

This document provides guidance on infection prevention and control (IPC) measures to healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) in order to prevent COVID-19 infection.

This document is intended to facilitate the dialogue between public health authorities and app developers to ensure that the main epidemiological and operational considerations are taken into account, while also understanding the technological limitations.